Here we demonstrate within mutant (A246E and M146L) PS1-expressing human neuronal networks, the confluence of complex AD pathologies including Aβ, tau hyper-phosphorylation, calcium dyshomeostasis, and neuroinflammation, thus providing a clinically relevant platform with which to identify effective therapeutic targets. This evidence concerns the gene PSEN1 and Alzheimer disease.